BTG PLC (BTG.L)
28 Aug 2015
* Health Canada has issued a notice of compliance approving Varithena
LONDON, May 19 - British pharmaceutical company BTG said its full-year profit was dampened by investment in new products, including its Varithena varicose veins treatment in the United States.
* Fy pretax profit 26.7 million stg versus 33.3 million stg year ago
LONDON, April 2 - British drugs company BTG nudged up its 2014/15 revenue forecast on Thursday and said it was on course for further strong growth in its new financial year.